Accuray, Inc. (ARAY)
2.14
+0.02
(+0.94%)
USD |
NASDAQ |
Nov 20, 10:35
Accuray Cash from Operations (Quarterly) : -4.657M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -4.657M |
| June 30, 2026 | 2.427M |
| March 31, 2026 | -5.602M |
| December 31, 2025 | -15.99M |
| September 30, 2025 | 12.18M |
| June 30, 2025 | -9.708M |
| March 31, 2025 | 18.06M |
| December 31, 2024 | 1.801M |
| September 30, 2024 | -7.294M |
| June 30, 2024 | 9.882M |
| March 31, 2024 | -8.102M |
| December 31, 2023 | -5.093M |
| September 30, 2023 | -8.591M |
| June 30, 2023 | 8.881M |
| March 31, 2023 | 24.63M |
| December 31, 2022 | -18.01M |
| September 30, 2022 | 0.046M |
| June 30, 2022 | -4.644M |
| March 31, 2022 | -21.77M |
| December 31, 2021 | 32.61M |
| September 30, 2021 | -8.60M |
| June 30, 2021 | 6.695M |
| March 31, 2021 | 15.90M |
| December 31, 2020 | 18.78M |
| September 30, 2020 | -2.87M |
| Date | Value |
|---|---|
| June 30, 2020 | 18.82M |
| March 31, 2020 | -12.12M |
| December 31, 2019 | 16.45M |
| September 30, 2019 | -24.62M |
| June 30, 2019 | 9.086M |
| March 31, 2019 | -7.129M |
| December 31, 2018 | -13.78M |
| September 30, 2018 | -17.82M |
| June 30, 2018 | 27.89M |
| March 31, 2018 | 4.185M |
| December 31, 2017 | -0.713M |
| September 30, 2017 | -13.03M |
| June 30, 2017 | 23.68M |
| March 31, 2017 | -12.25M |
| December 31, 2016 | -5.039M |
| September 30, 2016 | -6.771M |
| June 30, 2016 | 19.79M |
| March 31, 2016 | -8.24M |
| December 31, 2015 | 7.074M |
| September 30, 2015 | 12.26M |
| June 30, 2015 | -1.777M |
| March 31, 2015 | 0.382M |
| December 31, 2014 | 1.734M |
| September 30, 2014 | -14.72M |
| June 30, 2014 | -0.325M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Orthofix Medical, Inc. | 0.498M |
| ResMed, Inc. | 422.42M |
| Rockwell Medical, Inc. | -1.526M |
| Microbot Medical, Inc. | -5.407M |
| Stereotaxis, Inc. | -4.177M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -5.004M |
| Cash from Financing (Quarterly) | 11.16M |
| Free Cash Flow | -37.28M |
| Free Cash Flow Per Share (Quarterly) | -2.775 |
| Free Cash Flow to Equity (Quarterly) | 42.08M |
| Free Cash Flow to Firm (Quarterly) | 1.645M |
| Free Cash Flow Yield | -582.7% |